Bonesupport: Positively reviewed long-term outlooks - Redeye

Redeye raises its fair value range following a review of BONESUPPORT’s long-term potential. Our updated and lengthened financial forecast better reflects the company’s strong value proposition, which we believe positions CERAMENT well for becoming a paradigm shift driver towards locally eluting antibiotic synthetic bone grafts in bone defect treatment.

Länk till analysen i sin helhet: https://www.redeye.se/research/859201/bonesupport-positively-reviewed-long-term-outlooks?utm_source=finwire&utm_medium=RSS